Alvotech - Ordinary Shares, nominal value of $0.01 per share (ALVO) Institutional Ownership

CUSIP: L01800108

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Type / Class
Equity / Ordinary Shares, nominal value of $0.01 per share
Symbol
ALVO on Nasdaq
Shares outstanding
311,860,120
Price per share
$4.16
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
15,527,894
Total reported value
$78,052,031
% of total 13F portfolios
0%
Share change
-91,033
Value change
-$1,136,717
Number of holders
48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP L01800108?
CUSIP L01800108 identifies ALVO - Alvotech - Ordinary Shares, nominal value of $0.01 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Alvotech - Ordinary Shares, nominal value of $0.01 per share (ALVO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Aztiq Pharma Partners S.a r.l. 33% $533,786,019 103,849,420 Aztiq Pharma Partners S.a r.l. 17 Dec 2025

As of 31 Dec 2025, 48 institutional investors reported holding 15,527,894 shares of Alvotech - Ordinary Shares, nominal value of $0.01 per share (ALVO). This represents 5% of the company’s total 311,860,120 outstanding shares.

Institutional Holders of Alvotech - Ordinary Shares, nominal value of $0.01 per share (ALVO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 15,527,894 $78,052,031 -$1,136,717 $5.13 48
2025 Q3 15,616,027 $127,787,483 -$23,088,302 $8.19 64
2025 Q2 17,039,963 $155,800,629 +$5,013,997 $9.12 51
2025 Q1 16,466,684 $158,801,696 +$14,857,882 $9.67 49
2024 Q4 15,209,918 $199,269,907 +$3,473,265 $13.23 44
2024 Q3 14,991,393 $177,990,036 +$13,702,862 $11.90 31
2024 Q2 13,787,759 $167,164,357 +$3,525,463 $12.16 29
2024 Q1 13,458,693 $164,634,428 -$39,286,607 $12.22 20
2023 Q4 16,791,901 $192,815,783 -$1,109,006 $11.48 17
2023 Q3 17,081,113 $155,823,907 +$3,190,655 $9.12 18
2023 Q2 16,799,973 $130,224,317 -$11,628,070 $7.74 16
2023 Q1 18,955,901 $244,613,904 +$2,723,422 $12.90 17
2022 Q4 18,747,770 $184,711,213 -$11,915,244 $10.00 11
2022 Q3 20,765,078 $140,565,000 +$9,057,505 $6.76 14
2022 Q2 19,414,528 $157,758,000 +$157,758,000 $8.21 17